DIRS.INFO The most relevant business & tech news

Small icons of scientific papers are lined up in a grid, each representing a study of medication abortion. Studies of abortion pills Each icon represents one study that reported serious complications after medication abortion. For pregnant women considering medication abortion, the alternatives would be childbirth or procedural abortion. Almost all patients will experience bleeding and pain during a medication abortion, because the pills essentially trigger a miscarriage. But the study itself notes that bleeding is expected, serious complications are rare and medication abortion is safe.

☆ Abortion pill mifepristone ruling in Texas case could hinge on 1873 Comstock Act
▼ + stars: | 2023-03-21 | by ( Spencer Kimball | ) www.cnbc.com time to read: +6 min

A federal judge in Texas may try to invoke an obscure 19th-century law called the Comstock Act to roll back mail delivery of the abortion pill mifepristone. His rationale could hinge in part on the Comstock Act. The anti-abortion group's attorneys argued that the Comstock Act and other laws ban mail delivery of mifepristone. The Comstock Act has not been enforced in decades, said Rachel Rebouche, an expert on reproductive health law at Temple University. Congress passed the Comstock Act in 1873 after an anti-vice crusader named Anthony Comstock successfully lobbied lawmakers to declare "obscene" materials as not mailable.

☆ U.S. judge in Texas will soon rule on the abortion pill mifepristone. Here's what could happen
▼ + stars: | 2023-03-17 | by ( Spencer Kimball | ) www.cnbc.com time to read: +7 min

The Alliance For Hippocratic Medicine wants Judge Kacsmaryk to nullify the FDA's medical approval of mifepristone, which would effectively ban the abortion pill across the US. Senate Judiciary Committee | YouTubeA Texas judge will soon issue a pivotal ruling in a closely watched case challenging the Food and Drug Administration's approval of the abortion pill mifepristone. It's also possible that Kacsmaryk could order the agency to impose tighter restrictions on access to mifepristone but stop short of completely halting sales. Abortion rights groups and legal experts expect the judge will rule against the FDA in some form. Possible injunctionIf Kacsmaryk issues an order to withdraw mifepristone from the market, there are several ways such a ruling could be drafted.

March 15 (Reuters) - A U.S. judge in Texas is set to hear arguments on Wednesday in a bid by anti-abortion groups to ban sales of the abortion pill mifepristone across the country, even in states where abortion is legal, as they challenge regulatory approval granted more than two decades ago. Twelve of the 50 states now ban abortion outright while some others prohibit it after a certain length of pregnancy, according to the Guttmacher Institute, a research organization that supports abortion rights. The judge cited death threats and harassment directed at the court during the case and a wish to avoid disruption. After appealing to the 5th Circuit, the losing side could seek to take the matter to the U.S. Supreme Court. Reporting by Brendan Pierson in New York; Editing by Will Dunham and Alexia GaramfalviOur Standards: The Thomson Reuters Trust Principles.

☆ Citing 'death threats,' Texas judge asked attorneys to keep news of hearing on legality of abortion pill quiet
▼ + stars: | 2023-03-14 | by ( Spencer Kimball | ) www.cnbc.com time to read: +4 min

The Alliance For Hippocratic Medicine wants Judge Kacsmaryk to nullify the FDA's medical approval of mifepristone, which would effectively ban the abortion pill across the US. But Kacsmaryk asked the attorneys to not to publicize the hearing, citing security concerns. Those present at the Friday conference call included lawyers from the Justice Department, the abortion pill maker Danco Laboratories, and a group that opposes abortion called the Alliance Defending Freedom. A group of physicians who oppose abortion called the Alliance for Hippocratic Medicine asked Kacsmaryk in November to order the Food and Drug Administration to withdraw its approval of the abortion pill mifepristone. The abortion pill has become the central flashpoint in the legal battle over access to abortion in the wake of the Supreme Court's ruling that overturned Roe v. Wade last June.

☆ UK growth demands better-directed fiscal fireworks
▼ + stars: | 2023-03-13 | by ( Francesco Guerrera | ) www.reuters.com time to read: +7 min

As a former health minister, Hunt is familiar with the Hippocratic Oath’s principle of “first, do no harm.” That credo didn’t resonate with former finance minister Kwasi Kwarteng. The Institute for Fiscal Studies estimates that borrowing in the current financial year is running 31 billion pounds below the November forecast by the Office for Budget Responsibility (OBR), the UK’s independent fiscal watchdog. A further 6 billion pounds will freeze fuel duties, avoiding a 23% rise from April. In November, the OBR forecast that Downing Street would meet that goal with just 9.2 billion pounds to spare. That would still cost 11 billion pounds a year but would boost investment by 5% in the long run.

☆ An anti-abortion judge overseeing a Texas lawsuit that could ban an abortion pill wanted to delay announcing the hearing date, The Washington Post reported
▼ + stars: | 2023-03-12 | by ( Lloyd Lee | ) www.businessinsider.com time to read: +6 min

Judge Matthew Kacsmaryk is overseeing a lawsuit that challenges the FDA approval of mifepristone. A hearing was scheduled for Wednesday, but the judge hoped to delay publicizing the date, per WaPo. But the Texas judge overseeing the case — who is known for his conservative politics and anti-abortion stance — hoped to hide the date of the hearing until right before the scheduled date, The Washington Post reported. In addition, he told attorneys on the call that members of the courthouse have received threats due to the lawsuit, the Post reported. According to the report, the Post had attempted to seek information about the date of the hearing before the Friday call but received no response.

☆ Where Restrictions on Abortion Pills Could Matter Most
▼ + stars: | 2023-03-02 | by ( Allison Mccann | Amy Schoenfeld Walker | ) www.nytimes.com time to read: +10 min

Abortion providers in the United States A United States map shows the location of abortion providers in states without abortion bans. total abortions Medication abortions 71,700 61,500 58% 37,500 32,100 28,800 29,500 41% 61% 60% 51% 52% Florida New York Georgia Pa. Mich. N.C. N.J. Ohio Wash. Mass. Some ways the ruling could affect the availability of abortion pills A flowchart shows possible outcomes from a judge’s ruling and highlights how abortion pills could remain available under some scenarios. Even if the judge rules in favor of the plaintiffs, abortion pills could remain available. The foundation’s Wichita, Kansas, clinic sees more than 500 patients a month, many from Texas, and 60 percent choose abortion pills.

☆ Who is Matthew Kacsmaryk, the Trump-appointed Texas judge who could ban abortion pills?
▼ + stars: | 2023-02-26 | by ( Lloyd Lee | ) www.businessinsider.com time to read: +8 min

Matthew Kacsmaryk is a Texas federal judge who was nominated by Donald Trump in 2017. Kacsmaryk graduated from Abilene Christian University in 1999 and received his law degree from the University of Texas School of Law in 2003. The Post reported that it was during law school when Kacsmaryk focused on abortion rights. Kacsmaryk also served as the executive editor of the Texas Review of Law & Politics and received two Dean's Achievement Awards, according to the questionnaire. During his undergraduate years, studying political science, Kacsmaryk was outspoken about his conservative views and stances on abortion.

Feb 21 (Reuters) - A Texas federal judge on Tuesday refused to set an accelerated trial schedule for a lawsuit by anti-abortion groups seeking to end U.S. sales of the abortion pill mifepristone, in a case that could severely disrupt access to medication abortion nationwide. Mifepristone is approved for medication abortion in the first 10 weeks of pregnancy in combination with another drug, misoprostol. Medication abortion accounts for more than half of U.S. abortions. Medication abortion has drawn increasing attention since the U.S. Supreme Court last year reversed its landmark 1973 Roe v. Wade ruling, which had guaranteed abortion rights nationwide. President Joe Biden, a Democrat, directed federal agencies to expand access to medication abortion in response to the decision, which has allowed more than a dozen Republican-led states to adopt new abortion bans.

☆ Childbirth is far more dangerous for women than the abortion pill, American Medical Association tells the Texas judge weighing mifepristone ban
▼ + stars: | 2023-02-16 | by ( Charles R. Davis | ) www.businessinsider.com time to read: +5 min

The American Medical Association is urging a Texas judge to reject an effort to ban mifepristone. This is not an opinion — it is a fact based on hundreds of medical studies and vast amounts of data amassed over the course of two decades," the brief states. But pregnant teenagers, the medical groups note, have levels of progesterone far greater than their non-pregnant peers. "There is no reason to think, nor is there evidence to show, that preventing the absorption of progesterone for a brief window would have any effects on adolescent development," the brief states. Republican attorneys general also submitted a brief arguing that the availability of the drug infringes on the right of states to regulate abortion.

☆ There will be an 'unprecedented spike' in maternal mortality if a Trump-appointed judge bans the abortion pill, Democratic attorneys general argue
▼ + stars: | 2023-02-14 | by ( Charles R. Davis | ) www.businessinsider.com time to read: +7 min

Banning mifepristone will result in more women dying in pregnancy, Democratic attorneys general argued this month. The argument comes as a judge in Texas is considering a ban on the abortion pill. Republican attorneys general who have weighed in on the case also maintain that its approval infringed on state rights. In her brief, James noted that carrying a pregnancy to term poses significantly greater health risks than an early abortion. As Slate's Christina Cautertucci notes, mifepristone is only one of the two drugs used in a typical medication abortion.

☆ Judge extends deadline in lawsuit seeking to pull abortion pill mifepristone from U.S. until Feb. 24
▼ + stars: | 2023-02-10 | by ( Spencer Kimball | ) www.cnbc.com time to read: +3 min

A federal judge in Texas has extended until Feb. 24 the deadline in a lawsuit seeking to overturn the Food and Drug Administration's approval of the abortion pill. The abortion rights group NARAL Pro-Choice America, in an analysis published Friday, said 40 million women would lose access to the abortion pill if the Alliance for Hippocratic Medicine succeeds and mifepristone is effectively banned. It would also weaken the FDA's drug approval powers and hinder drug development by creating regulatory uncertainty in the marketplace. Two separate lawsuits are also seeking to overturn state restrictions on mifepristone, arguing that they conflict with FDA regulations. Republican attorneys general in 20 states also recently warned CVS and Walgreens against mailing the abortion pill in their states, indicating that they would take legal action.

Medication abortion has drawn increasing attention since the U.S. Supreme Court last year reversed its landmark 1973 Roe v. Wade ruling, which had guaranteed abortion rights nationwide. President Joe Biden, a Democrat, directed federal agencies to expand access to medication abortion in response to the decision. Mifepristone is used in combination with another drug, misoprostol, for medication abortion, which accounts for more than half of U.S. abortions. They said ending access to the drug would force patients to have unnecessary surgical abortions or prevent them from accessing abortion altogether. The Texas lawsuit could move quickly, as the plaintiffs in a filing on Friday asked Kacsmaryk to skip a hearing on a preliminary order and instead go straight to trial.

"It's judge shopping on steroids," said Sarah Lipton-Lubet, executive director of the progressive legal advocacy group Take Back the Court. The Biden administration has called the lawsuit "unprecedented" and urged Kacsmaryk to not deprive women of a long-approved safe and effective drug. At least eight have led to rulings blocking Biden policies, with several more pending. The chief judges of Texas federal courts have the authority to reallocate cases to other judges, but have largely not done so, he said. Absent a change, litigants have every right to take advantage of that structure to seek a favorable judge, he said.

☆ The FDA's power to approve drugs faces sweeping challenge in lawsuit seeking to pull abortion pill from U.S. market
▼ + stars: | 2023-01-24 | by ( Spencer Kimball | ) www.cnbc.com time to read: +7 min

The Alliance for Hippocratic Medicine asked a federal district court in Dallas late last year to declare the FDA approval unlawful and completely remove the abortion pill from the U.S. market. If the lawsuit prevails, women across the U.S. would lose access, at least temporarily, to the most commonly used abortion method. Judge Matthew Kacsmaryk is hearing the challenge to the FDA's approval of the abortion pill. Lawrence Gostin, an expert on public health law at Georgetown Law, said it would be "highly irresponsible" and "reckless" for a judge to overturn the FDA approval of mifepristone. Under federal law, lawsuits against the U.S. government must be filed within six years of an agency action.

Medication abortion has drawn increasing attention since the U.S. Supreme Court last June overturned its landmark 1973 Roe v. Wade decision that had legalized abortion nationwide. Nearly all abortions, including medication abortions, are now banned in 12 states, and 16 states that permit some abortions also had laws restricting medication abortion as of November, according to the Guttmacher Institute, a research group that supports abortion rights. "The FDA, by approving chemical abortion drugs for home use, puts a woman or girl's life at risk." In its court filing, the FDA said there was no basis for second-guessing the FDA's judgment. The FDA said that pulling the drug would force patients seeking abortions in many cases to undergo unnecessary and more invasive surgical abortion.

Audiences will see how the battle in the Texas Legislature over gender-affirming care for trans children is far from a mere partisan philosophical argument or campaign talking point for me. That’s the year a flood of anti-LGBTQ bills were introduced in the Texas Legislature — the majority of which directly targeted trans kids and their families. This year dealt Texas trans families a double blow when state Attorney General Ken Paxton delivered a nonbinding legal opinion that gender-affirming care for children was child abuse — followed by a directive from Gov. We acted quickly as a family, breaking the news of our pending out-of-state move to Noah over an unforgettably sad dinner. Despite it all, Texas is where our hearts reside, no matter how many miles might separate us and how directly damaging Republican rhetoric has been.

☆ Two Florida medical boards advance ban on gender-affirming care for minors
▼ + stars: | 2022-11-04 | by ( Zachary Schermele | ) www.nbcnews.com time to read: +4 min

Florida’s state medical boards voted Friday afternoon to approve the language of a first-of-its-kind rule banning gender-affirming care for transgender minors who don’t already receive it. The rule updates the medical standards of practice in the state to mostly prohibit health care professionals from starting treatment for gender dysphoria in those younger than 18. Gender dysphoria refers the stress and discomfort some experience when their gender identity doesn’t match their sex assigned at birth. The measure bans the prescription of puberty blockers or hormone therapy to new patients who are minors, and it forbids gender-affirming surgeries. In a statement Friday, Equality Florida said once the rule goes into effect, it will be the only ban in the country of gender-affirming care for minors instituted by a state medical board.

☆ ‘The Good Nurse’ Review: Hippocratic Hypocrite
▼ + stars: | 2022-10-26 | by ( John Anderson | ) www.wsj.com time to read: +1 min

As fascinating as they can be to watch, neither Eddie Redmayne nor Jessica Chastain ever has what we usually call chemistry with their co-stars. But isolated brilliance is precisely what helps “The Good Nurse” shine, and it could hardly be otherwise given the story. A true-crime drama at its core, this psycho thriller-cum-police procedural stars both actors as medical practitioners, one of whom is killing people. There’s never much pretense made about who the murderer is. These two are firmly in the friend zone, at least until patients start dropping dead.

Search resuls for: "Hippocratic"

20 mentions found